ATE360061T1 - Replikationsmangelhafte mutanten von herpesvirus - Google Patents
Replikationsmangelhafte mutanten von herpesvirusInfo
- Publication number
- ATE360061T1 ATE360061T1 AT95907356T AT95907356T ATE360061T1 AT E360061 T1 ATE360061 T1 AT E360061T1 AT 95907356 T AT95907356 T AT 95907356T AT 95907356 T AT95907356 T AT 95907356T AT E360061 T1 ATE360061 T1 AT E360061T1
- Authority
- AT
- Austria
- Prior art keywords
- replication
- herpesvirus
- herpes virus
- mutated
- mammal
- Prior art date
Links
- 241001529453 unidentified herpesvirus Species 0.000 title abstract 4
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229940124841 Herpesvirus vaccine Drugs 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000004957 immunoregulator effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16661—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17910694A | 1994-01-10 | 1994-01-10 | |
US08/278,601 US7223411B1 (en) | 1992-07-31 | 1994-07-21 | Herpesvirus replication defective mutants |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE360061T1 true ATE360061T1 (de) | 2007-05-15 |
Family
ID=26874996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95907356T ATE360061T1 (de) | 1994-01-10 | 1995-01-09 | Replikationsmangelhafte mutanten von herpesvirus |
Country Status (7)
Country | Link |
---|---|
US (1) | US7223411B1 (de) |
EP (1) | EP0739414B1 (de) |
JP (1) | JPH09508788A (de) |
AT (1) | ATE360061T1 (de) |
CA (1) | CA2180551A1 (de) |
DE (1) | DE69535466T2 (de) |
WO (1) | WO1995018852A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020009462A1 (en) * | 1992-07-31 | 2002-01-24 | David M. Knipe | Herpesvirus replication defective mutants |
EP0856062A2 (de) * | 1995-10-19 | 1998-08-05 | St. Jude Children's Research Hospital | Herpesvirus-vektoren und deren verwendung |
US20080226677A1 (en) * | 2004-05-06 | 2008-09-18 | Yasuko Mori | Recombinant virus vector for gene transfer into lymphoid cells |
US8257712B2 (en) * | 2008-07-03 | 2012-09-04 | Saint Louis University | Virus-expressing host costimulation molecules |
US8809047B2 (en) | 2009-12-21 | 2014-08-19 | The Brigham And Women's Hospital, Inc. | Herpes simplex virus vaccines |
CA2873775C (en) | 2012-05-21 | 2021-04-20 | Sanofi Pasteur Limited | Herpesvirus compositions and related methods |
SG11201505333PA (en) | 2013-01-08 | 2015-08-28 | Genzyme Corp | Use of inos inhibitors to increase viral yield in culture |
RU2531426C1 (ru) * | 2013-06-24 | 2014-10-20 | Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" | Способ лечения герпетического кератита |
US10350289B2 (en) | 2013-09-05 | 2019-07-16 | Merck Sharp & Dohme Corp. | Methods of immunization with varicella zoster virus antigen |
US11390650B2 (en) | 2018-02-05 | 2022-07-19 | The Brigham And Women's Hospital, Inc. | Recombinant Herpes Simplex Virus-2 expressing glycoprotein B and D antigens |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769331A (en) | 1981-09-16 | 1988-09-06 | University Patents, Inc. | Recombinant methods and materials |
US4554159A (en) | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
US4859587A (en) | 1984-06-04 | 1989-08-22 | Institut Merieux | Recombinant herpes simplex viruses, vaccines and methods |
US5288641A (en) | 1984-06-04 | 1994-02-22 | Arch Development Corporation | Herpes Simplex virus as a vector |
EP0213894A3 (de) | 1985-08-23 | 1987-10-21 | Advanced Genetics Research Institute | Defektive Viruspartikelimpfstoffe und Verfahren zur Anwendung derselben |
EP0277773A1 (de) | 1987-01-30 | 1988-08-10 | The Board Of Trustees Of The Leland Stanford Junior University | Mischcytomegalovirus und Vakzin |
CN1038306A (zh) | 1988-03-21 | 1989-12-27 | 维吉恩公司 | 重组反转录病毒 |
WO1990005538A1 (en) | 1988-11-14 | 1990-05-31 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Parvovirus capsids |
JP3140757B2 (ja) | 1989-02-06 | 2001-03-05 | デイナ・フアーバー・キヤンサー・インステイテユート | パッケージング欠陥hivプロウイルス、細胞系及びその使用 |
FR2663228A2 (fr) | 1989-09-29 | 1991-12-20 | Agronomique Inst Nat Rech | Composition immunisante contre la maladie de newcastle et procede de preparation. |
CA2039921A1 (en) | 1990-04-16 | 1991-10-17 | Xandra O. Breakefield | Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
US5328688A (en) | 1990-09-10 | 1994-07-12 | Arch Development Corporation | Recombinant herpes simplex viruses vaccines and methods |
US5837261A (en) * | 1990-09-25 | 1998-11-17 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
US5665362A (en) | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
DK0550553T3 (da) * | 1990-09-25 | 2000-10-23 | Cantab Pharma Res | Viral defekt vaccine fremstillet af en transkomplementerende cellelinie |
TW289731B (de) | 1992-07-09 | 1996-11-01 | Akzo Nv | |
DE69333751T2 (de) | 1992-07-30 | 2005-12-29 | Akzo Nobel N.V. | Nicht-verbreitendes lebendes herpesvirusvakzin |
US5804413A (en) * | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
CA2141574C (en) | 1992-07-31 | 2009-11-24 | David Knipe | Herpesvirus vaccines |
US5879934A (en) * | 1992-07-31 | 1999-03-09 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
US5658724A (en) * | 1992-07-31 | 1997-08-19 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use |
WO1994021807A2 (en) | 1993-03-19 | 1994-09-29 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
-
1994
- 1994-07-21 US US08/278,601 patent/US7223411B1/en not_active Expired - Lifetime
-
1995
- 1995-01-09 AT AT95907356T patent/ATE360061T1/de not_active IP Right Cessation
- 1995-01-09 EP EP19950907356 patent/EP0739414B1/de not_active Expired - Lifetime
- 1995-01-09 CA CA 2180551 patent/CA2180551A1/en not_active Abandoned
- 1995-01-09 WO PCT/US1995/000278 patent/WO1995018852A1/en active IP Right Grant
- 1995-01-09 JP JP51865895A patent/JPH09508788A/ja not_active Ceased
- 1995-01-09 DE DE1995635466 patent/DE69535466T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH09508788A (ja) | 1997-09-09 |
DE69535466D1 (de) | 2007-05-31 |
US7223411B1 (en) | 2007-05-29 |
WO1995018852A1 (en) | 1995-07-13 |
EP0739414B1 (de) | 2007-04-18 |
DE69535466T2 (de) | 2008-01-03 |
CA2180551A1 (en) | 1995-07-13 |
EP0739414A1 (de) | 1996-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69332501D1 (en) | Herpesvirus impfstoffe | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
CA2596274A1 (en) | Recombinant mva virus, and the use thereof | |
DK0835133T3 (da) | Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf | |
JP2003502008A5 (de) | ||
HUP0102478A2 (hu) | A HCV-burokfehérjék által alkotott részecskék alkalmazása vakcinázásban | |
ATE360061T1 (de) | Replikationsmangelhafte mutanten von herpesvirus | |
EP0232798A3 (de) | Pseudorabies-Virus-Mutanten, diese enthaltende Vakzine, Verfahren zu deren Herstellung sowie Methoden für deren Anwendung | |
AU6489986A (en) | Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same | |
MX26715A (es) | Procedimiento para la preparacion de particulas antigenicas del virus de la hepatitis b en levaduras metilotroficas. | |
EP0541692A4 (en) | Herpes simplex virus vp16 vaccines | |
SE7504221L (sv) | Cellvirusvaccin och forfarande for framstellning av vaccinet. | |
FR2702152B1 (fr) | Virus recombinants et leur utilisation en thérapie génique. | |
DK0956045T3 (da) | Samlingsdeficient herpesvirusvaccine | |
AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
Kuklin et al. | Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines | |
AU6383296A (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
EP1105157A4 (de) | Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt. | |
FI932759A0 (fi) | Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner | |
DK257887D0 (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
Xiao et al. | Experimental studies of a human diploid cell rabies vaccine for human use. | |
FI930519A0 (fi) | Peptider foer blokering av infektioner orsakade av hiv-virus samt foerfarande foer deras anvaendnig | |
Zhdanov | Some problems of biotechnology. | |
RU97115149A (ru) | Способ вакцинации против вирусного гепатита в | |
DE69841529D1 (de) | Tiermodell zur Berechnung von Impstoffen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |